We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Viking Therapeutics Inc
32 own
31 watching
Current Price
$11.67
$-1.21
(-9.43%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
1,966.32M
52-Week High
25.72000
52-Week Low
2.53500
Average Volume
3.39M
Dividend Yield
--
P/E Ratio
--
Market Capitalization1,966.32M52-Week High25.7200052-Week Low2.53500Average Volume3.39MDividend Yield--P/E Ratio--What does the Viking Therapeutics Inc do?
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapies for metabolic and endocrine disorders. Its lead clinical program includes VK0612, an orally available drug candidate for the treatment of type 2 diabetes. The company is also developing VK5211, an orally available drug candidate, which is in a Phase II clinical trial for acute rehabilitation following non-elective hip fracture surgery. In addition, it is developing VK0214, a novel liver-selective thyroid hormone receptor beta agonist for lipid disorders, such as dyslipidemia and nonalcoholic steatohepatitis, as well as VK2809, an orally available, tissue, and receptor-subtype selective agonist of the thyroid beta receptor that is entering Phase II development for the treatment of patients with hypercholesterolemia and fatty liver disease. Viking Therapeutics, Inc. was founded in 2012 and is headquartered in San Diego, California.
Read More
How much money does Viking Therapeutics Inc make?
News & Events about Viking Therapeutics Inc.
PR Newswire
3 months ago
Thinking about buying stock in Applied Digital, Workhorse Group, Marathon Digital Holdings, Viking Therapeutics, or Eton Pharmaceuticals? Thinking about buying stock in Applied Digital, Workhorse Group, Marathon Digital Holdings, Viking Therapeutics, or Eton Pharmaceuticals? PR Newswire NEW YORK...
Fool.com Headlines
3 months ago
All three healthcare stocks have soared this year, but their share prices may not be sustainable.Nano-X Imaging (NASDAQ: NNOX), DermTech (NASDAQ: DMTK), and Viking Therapeutics (NASDAQ: VKTX) are healthcare growth stocks with plenty of potential, little revenue, and a boatload of risk.Share prices ...
PR Newswire
6 months ago
Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock PR Newswire SAN DIEGO, March 29, 2023 SAN DIEGO, March 29, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ('Viking"...
Fool.com Headlines
6 months ago
The clinical-stage stock nearly doubled in price.Shares of Viking Therapeutics (NASDAQ: VKTX) were up 89.7% for the week as of Thursday afternoon, after being up as much as 95.5% for the week, according to data provided byS&P Global Market Intelligence. The move up was largely due to positive early ...
Benzinga
7 months ago
read more...
Frequently Asked Questions
Frequently Asked Questions
What is Viking Therapeutics Inc share price today?
Can Indians buy Viking Therapeutics Inc shares?
How can I buy Viking Therapeutics Inc shares from India?
Can Fractional shares of Viking Therapeutics Inc be purchased?
What are the documents required to start investing in Viking Therapeutics Inc stocks?
What is today’s traded volume of Viking Therapeutics Inc?
What is today’s market capitalisation of Viking Therapeutics Inc?
What is the 52-Week High and Low Range of Viking Therapeutics Inc?
What percentage is Viking Therapeutics Inc down from its 52-Week High?
What percentage is Viking Therapeutics Inc up from its 52-Week Low?
Current Price
$11.67
$-1.21
(-9.43%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.